课题基金 / 基金详情

Administrative Core and Senior Leadership

Administrative Core and Senior Leadership
行政核心和高层领导
批准号:
10260747
负责人:
Carlos L Arteaga
金额:
$23.61万
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-08-03 至 2021-07-31

项目摘要

项目成果

Carlos L Arteaga的其他基金

相似基金

相关文献

中文摘要
翻译
Harold C.西蒙斯癌症中心 行政核心和高级领导 项目总结/摘要 西蒙斯癌症中心行政办公室的主要重点是提供高效和有效的 对所有癌症中心的运营进行行政、规划和财务领导,并为 癌症中心的财政支持,包括癌症中心支持补助金。具体目标是 核心支持这一理念,并指导本办公室的所有主要职能: ·保持及时、有效和高效的行政和财务职能,并确保其 与主要机构部门和办事处进行整合和协调; ·通过监测和评估研究成果指导西蒙斯癌症中心的战略规划, 影响,并向高级领导和机构高管汇报; ·通过促进协作,跨学科, 和多研究者研究;以及 ·管理与所有内部和外部成员的一致和有效的沟通。 自2009年以来,癌症中心管理局在满足日益增长的 癌症中心年度预算总额从3 370万美元增加到7 630万美元;管理的工作人员总数为 2009年为192个,现在为382个。此外,新的行政数据和信息系统, 癌症中心的研究已与机构部门联合实施。在这个相同的 在此期间,癌症中心成员的数量从112人增加到164人。癌 中心管理还对同行评审资助项目的显著增加做出了回应, 总计1.02亿美元(2009年为6420万美元),年度临床试验应计费用为1,221项,2009年为633项。 2009. 高级领导团队,除了主任,詹姆斯威尔逊,医学博士,包括琼席勒,医学博士, 副主任; Michael白色博士,基础科学副主任; Celette Skinner博士,副主任 人口科学主任; Jerry Shay博士,培训和教育副主任; Tim Strawderman博士,研究管理副总监。这个领导团队自2007年以来一直在一起, 为中心战略计划的制定和实施提供补充专业知识, 方案评价重要的是,每一位高级领导者都是公认的,并受到整个行业同行的尊重。 UTSW校园,并一直在建设参与和提高认识, 参与该中心,并负责制定方向,实施倡议,并在内部 评价这组领导人一直特别致力于项目建设,招聘, 指导。
英文摘要
Harold C. Simmons Cancer Center Administrative Core and Senior Leadership Project Summary/Abstract The primary focus of the Simmons Cancer Center Administrative Office is to provide efficient and effective administrative, planning, and financial leadership to all Cancer Center operations, and deliver added value to the Cancer Center's financial support, including the Cancer Center Support Grant. The specific aims for this Core support this philosophy and guide all primary functions of this office: • Maintain timely, effective, and efficient administrative and financial functions, and ensure that they are integrated and coordinated with key institutional departments and offices; • Guide Simmons Cancer Center strategic planning by monitoring and evaluating research outcomes and impact, and reporting back to Senior Leaders and Institutional Executives; • Deliver value-added support to Cancer Center members by facilitating collaborative, transdisciplinary, and multi-investigator research; and • Manage consistent and effective communications with all internal and external constituents. Since 2009, Cancer Center Administration has made significant progress in meeting the needs of a growing cancer center. The total annual budget is now $76.3 million, up from $33.7; while the total staff managed are now 382, compared with 192 in 2009. As well, new administrative data and information systems that support Cancer Center research have been implemented in conjunction with institutional departments. Over this same period the number of programmatically aligned Cancer Center members increased from 112 to 164. Cancer Center Administration has also responded to a marked increase in peer-reviewed funded projects, which now total $102 million (up from $64.2 million in 2009), and annual clinical trial accruals of 1,221, up from 633 in 2009. The Senior Leadership team that in addition to the Director, James Willson, MD, includes Joan Schiller, MD, Deputy Director; Michael White, PhD, Associate Director-Basic Science; Celette Skinner, PhD, Associate Director-Population Science; Jerry Shay, PhD, Associate Director-Training and Education; and Tim Strawderman, PhD, Associate Director-Research Administration. This leadership team, together since 2007, brings complementary expertise to development and implementation of the Center's strategic plan as well as program evaluation. Importantly, each senior leader is well established and respected by peers across the UTSW campus and has been highly effective in building engagement and increased awareness and participation in the Center and is responsible for setting direction, implementing initiatives, and internal evaluation. This group of leaders has been particularly committed to program building, recruitment, and mentoring.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Neoadjuvant Neratinib in Stage I-III HER2-mutated Lobular Breast Cancer
Role of HER2 mutations in breast cancer progression and response to targeted therapies
  • 批准号:
    9759820
  • 项目类别:
  • 资助金额:
    $35.74万
  • 财政年份:
    2018
  • 负责人:
    Carlos L Arteaga
  • 依托单位:
Role of HER2 mutations in breast cancer progression and response to targeted therapies
  • 批准号:
    10214565
  • 项目类别:
  • 资助金额:
    $36.83万
  • 财政年份:
    2018
  • 负责人:
    Carlos L Arteaga
  • 依托单位:
Role of HER2 mutations in breast cancer progression and response to targeted therapies
  • 批准号:
    10458531
  • 项目类别:
  • 资助金额:
    $36.09万
  • 财政年份:
    2018
  • 负责人:
    Carlos L Arteaga
  • 依托单位:
海外基金